Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
OSLO, Norway, March 14, 2014 (GLOBE NEWSWIRE) -- Dr. Ramdahl succeeds Algeta's former CEO Andrew Kay. Thomas Ramdahl has been with Algeta in various leadership roles since 2001, including serving...
-
OSLO, Norway, Feb. 26, 2014 (GLOBE NEWSWIRE) -- Algeta ASA ("Algeta"; OSE: ALGETA) today reported that Bayer has announced that 97.28% of all Algeta shares have been tendered to Aviator Acquisition...
-
OSLO, Norway, Feb. 5, 2014 (GLOBE NEWSWIRE) -- Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, announces its financial results for the fourth...
-
OSLO, Norway, Jan. 20, 2014 (GLOBE NEWSWIRE) -- Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, announces an update to its financial...
-
OSLO, Norway, Jan. 20, 2014 (GLOBE NEWSWIRE) -- Algeta ASA ("Algeta"; OSE: ALGETA) today announced that Aviator Acquisition AS, a wholly-owned subsidiary of Bayer Nordic SE, has commenced the...
-
OSLO, Norway, Jan. 6, 2014 (GLOBE NEWSWIRE) -- Algeta ASA ("Algeta"; OSE: ALGETA) today announced that regulatory approval by German competition authorities, specifically the Federal Cartel Office...
-
Intended for US media only Offer at NOK 362 per Algeta share, in cash, valuing the total share capital of Algeta at approximately NOK 17.6 billion (USD 2.9 billion) on a fully diluted...
-
In response to recent media commentary, the Board of Directors of Algeta ASA confirms that it is in receipt of a preliminary acquisition proposal from Bayer AG. The commentary in the media...
-
OSLO, Norway, Nov. 18, 2013 (GLOBE NEWSWIRE) -- Intended for US media only Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, will host Capital...
-
OSLO, Norway, Nov. 15, 2013 (GLOBE NEWSWIRE) -- Intended for US media only Oslo, Norway, 15 November 2013 - Algeta ASA (OSE: ALGETA) announces today that Bayer has received marketing ...